Nu Skin Enterprises (NUS) Misses Q1 EPS by 13c, provides guidance

Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.14, $0.13 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $320.6 million versus the consensus estimate of $356.8 million.

GUIDANCE:

Nu Skin Enterprises sees Q2 2026 EPS of $0.15-$0.25, versus the consensus of $0.23. Nu Skin Enterprises sees Q2 2026 revenue of $330-360 million, versus the consensus of $361 million.

Nu Skin Enterprises sees FY2026 EPS of $0.80-$1.20, versus the consensus of $1.00. Nu Skin Enterprises sees FY2026 revenue of $1.35-1.5 billion, versus the consensus of $1.427 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval